PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1717027-1	1991	Bestatin (ubenimex), the microbial leucil-aminopeptidase B inhibitor, has been shown previously to stimulate both interleukin-1 (IL-1) and IL-2 production and to enhance T-cell, as well as macrophage mediated immunoreaction when administered in vivo in mice.	ubenimex	0-8	interleukin 2	Mus musculus	139-143	
1717027-1	1991	Bestatin (ubenimex), the microbial leucil-aminopeptidase B inhibitor, has been shown previously to stimulate both interleukin-1 (IL-1) and IL-2 production and to enhance T-cell, as well as macrophage mediated immunoreaction when administered in vivo in mice.	ubenimex	10-18	interleukin 2	Mus musculus	139-143	
21059319-25	2001	CONCLUSIONS: Ubenimex may increase the OKT4 / T8 ratio, the NK cell activity and the IL-2 value and decrease the SIL-2R level of patients with squamous cell lung carcinoma.	ubenimex	13-21	interleukin 2	Mus musculus	85-89	
3496857-8	1987	Release of Interleukin-1 and -2 was enhanced by Bestatin treatment in vitro.	ubenimex	48-56	interleukin 2	Mus musculus	11-31	
3494719-0	1987	Enhancement of interleukin 1 and interleukin 2 releases by ubenimex.	ubenimex	59-67	interleukin 2	Mus musculus	33-46	
3494719-1	1987	The effect of ubenimex on the release of interleukin 1 (IL-1) and interleukin 2 (IL-2) from immuno-competent cells was studied.	ubenimex	14-22	interleukin 2	Mus musculus	66-79	
3494719-1	1987	The effect of ubenimex on the release of interleukin 1 (IL-1) and interleukin 2 (IL-2) from immuno-competent cells was studied.	ubenimex	14-22	interleukin 2	Mus musculus	81-85